These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1709212)

  • 1. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
    Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
    [No Abstract]   [Full Text] [Related]  

  • 3. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
    Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract]   [Full Text] [Related]  

  • 5. The predictive value of pre-orchidectomy serum tumor markers in non seminomatous germ cell tumors of the testis (N.S.G.C.T.T.).
    Boccon-Gibod L; Le Doze H; Steg A
    Prog Clin Biol Res; 1985; 203():93-5. PubMed ID: 2421347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
    Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early identification of therapeutic failure in nonseminomatous germ cell tumors by assessing serum tumor marker decline during chemotherapy: still not ready for routine clinical use.
    Toner GC
    J Clin Oncol; 2004 Oct; 22(19):3842-5. PubMed ID: 15302908
    [No Abstract]   [Full Text] [Related]  

  • 8. [Testis cancer markers. Clinical use].
    Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
    Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of plasma tumor markers in germinal tumors of the testis].
    Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
    Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers in germinal testis tumors.
    Perrin P; Ardiet C; Pommatau E
    Acta Urol Belg; 1985; 53(2):199-222. PubMed ID: 2409781
    [No Abstract]   [Full Text] [Related]  

  • 12. Testicular tumors.
    Lightner DJ; Lange PH
    Immunol Ser; 1990; 53():397-401. PubMed ID: 1713066
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum markers in germ cell neoplasms.
    Bartlett NL; Freiha FS; Torti FM
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1245-60. PubMed ID: 1723408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer.
    Lange PH; Hakala TR; Fraley EE
    Minn Med; 1975 Nov; 58(11):813-5. PubMed ID: 53783
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Schatte EC; Lerner SP
    J Urol; 2000 Nov; 164(5):1670. PubMed ID: 11203071
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-seminomatous germ cell tumors of the testis. Immunohistochemical localization and serum levels of human chorionic gonadotropin (HCG) and pregnancy-specific beta-1 glycoprotein (SP-1); value of SP-1 as a tumor marker.
    Suurmeijer AJ; De Bruijn HW; Oosterhuis JW; Sleyfer DT; Koops HS; Fleuren GJ
    Oncodev Biol Med; 1982; 3(5-6):409-22. PubMed ID: 6292873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
    Suurmeijer AJ; Oosterhuis JW; Marrink J; De Bruin HW; Schraffordt Koops H; Sleijfer DT; Fleuren GJ
    Oncodev Biol Med; 1983; 4(4):289-308. PubMed ID: 6188132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assay of chorionic gonadotrophin, follicle-stimulating hormone and alpha-fetoprotein in the efferent blood in germinal tumors of the testis].
    Henry R; Wiriot G; Longeon A; Timbal Y; Degrelle H
    Presse Med; 1986 Jun; 15(26):1223-6. PubMed ID: 2428029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T; Goepel M; Seeber S; Rübben H
    Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.